Dr Reddys Laboratories Hits 52-Week High, Receives 'Buy' Call from MarketsMOJO

Dr Reddys Laboratories, a leading pharmaceutical company, has recently reached a new milestone as its stock price hit a 52-week high on August 8th, 2024. This positive development has been noted by MarketsMOJO, who have given a 'Buy' call for the company's stock.

The stock price of Dr Reddys Laboratories has been on an upward trend, with the latest high of Rs.7036.25 being the highest in the past 52 weeks. This performance has also outperformed the sector by 1%, indicating the company's strong position in the market.

In the past two days, the stock has shown consecutive gains and has risen by 3.25%, showcasing its consistent growth. Furthermore, Dr Reddys Labs is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend for the company.

In comparison to the Sensex performance, Dr Reddys Laboratories has shown a 23.98% growth in the past year, while the Sensex has only grown by 20.29%. This further highlights the company's strong performance and potential for future growth.

Dr Reddys Laboratories is a largecap company in the pharmaceutical industry, known for its high-quality products and innovative research. With its recent achievements and positive outlook, it is no surprise that MarketsMOJO has given a 'Buy' call for its stock. Investors can look forward to a promising future with Dr Reddys Laboratories.